Though it has been eclipsed lately by SARS-CoV-2, there is another global epidemic still threatening people: HIV/AIDS. According to UNAIDS, a United Nations initiative, some 38 million people worldwide are currently infected ...
Mar 29, 2022
0
822
A multicenter collaboration tracking the spread and evolution of the SARS-CoV-2 virus in Saudi Arabia has identified mutations in the virus's N protein associated with increased viral loads in COVID-19 patients. The study ...
Mar 28, 2022
0
224
Some therapies successful in treating rheumatoid arthritis (RA) may help us better understand how to treat people with debilitating mosquito-borne viral diseases, new Griffith University research has found.
Mar 8, 2022
1
59
Research led by scientists at the MRC-University of Glasgow Centre for Virus Research and the University of Oxford, in collaboration with UKHSA and Brighton NHS have revealed new insights into transmissibility of variants ...
Jan 31, 2022
0
64
HIV replication in the human body requires that specific viral RNAs be packaged into progeny virus particles. A new study has found how a small difference in the RNA sequence can allow the viral RNA to be packaged for replication, ...
Dec 15, 2021
0
76
A research team at Aarhus University has developed a new molecule that attaches to the surface of SARS-CoV-2 virus particles. This attachment prevents the virus from entering human cells and spreading the infection.
Dec 13, 2021
0
1018
The United States recently secured 1.7 million doses of a compound that could help to treat COVID-19 patients. In preliminary studies, Molnupiravir reduced the transmission of the SARS-CoV-2 coronavirus. Researchers at the ...
Aug 16, 2021
0
1070
The coronavirus that causes COVID-19 has demonstrated a stubborn ability to resist most nucleoside antiviral treatments, but a new study led by an Iowa State University scientist could help to overcome the virus's defenses.
Aug 3, 2021
0
920
Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind. But HIV's ability to mutate isn't unique among RNA viruses—most viruses ...
Jul 2, 2021
0
149
Researchers from the Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the LIH Department of Oncology (DONC) are working on the development of novel anticancer strategies based on oncolytic viruses, 'good' viruses ...
Jun 29, 2021
0
22
